GnRH
Showing 1 - 25 of 1,007
Ovarian Stimulation, Human Chorionic Gonadotropin, Oocyte Donors Trial in Thessaloniki (Dual trigger (human chorionic
Recruiting
- Ovarian Stimulation
- +2 more
- Dual trigger (human chorionic gonadotropin plus GnRH-agonist)
- GnRH-agonist only trigger
-
Thessaloniki, GreeceEmbryolab Fertility Clinic
Nov 20, 2023
In Vitro Fertilization, ICSI Intracytoplasmic Spermatozoid Injection Trial in Bondy (Ovulation induction with hCG + Luteal phase
Not yet recruiting
- In Vitro Fertilization
- ICSI Intracytoplasmic Spermatozoid Injection
- Ovulation induction with hCG + Luteal phase support with vaginal progesterone
- Ovulation triggering by Triptorelin + Luteal phase support by Nafarelin
-
Bondy, FranceMaeliss Peigné
Nov 27, 2023
Angiogenesis, Endometriosis Trial in Patra, Yonago (Leuprolide Acetate)
Completed
- Angiogenesis
- Endometriosis
- Leuprolide Acetate
-
Patra, Peloponnese, Greece
- +1 more
Oct 27, 2023
Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility Trial (ultrashort GnRHa, short GnRHa, long GnRHa)
Not yet recruiting
- Intracytoplasmic Sperm Injection
- +3 more
- ultrashort GnRHa
- +2 more
- (no location specified)
Oct 2, 2022
Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles Trial in Jerusalem (GnRH agonist, Progesterone)
Active, not recruiting
- Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles
- GnRH agonist
- Progesterone
-
Jerusalem, IsraelShaare Zedek medical Center
Aug 1, 2022
IVF, PCO Trial in Bani Suwayf (Dydrogesterone Tablets, Cetrorelix)
Not yet recruiting
- IVF
- PCO
- Dydrogesterone Tablets
- Cetrorelix
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 16, 2023
Infertility, Female Trial in Worldwide (FE 999049 + GnRH agonist (GONAPEPTYL), FE 999049 + GnRH antagonist (CETROTIDE))
Completed
- Infertility, Female
- FE 999049 + GnRH agonist (GONAPEPTYL)
- FE 999049 + GnRH antagonist (CETROTIDE)
-
Dobl, Austria
- +15 more
Sep 28, 2022
Infertility Trial in Xi'an (Biosimilar cetrorelix acetate, Reference cetrorelix acetate)
Not yet recruiting
- Infertility
- Biosimilar cetrorelix acetate
- Reference cetrorelix acetate
-
Xi'an, None Selected, ChinaHe Cai
Sep 7, 2023
Premature Luteinisation, Progesterone Elevation Trial (GnRH antagonist)
Not yet recruiting
- Premature Luteinisation
- Progesterone Elevation
- GnRH antagonist
- (no location specified)
Mar 8, 2023
Prostate Cancer Trial in New Haven (Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment)
Not yet recruiting
- Prostate Cancer
- Relugolix 120 MG [Orgovyx]
- SBRT standard of care radiotherapy treatment
-
New Haven, ConnecticutYale Cancer Center
Oct 26, 2023
Diminished Ovarian Reserve Trial (Dydrogesterone priming ovarian stiumulation protocol, GnRH antagonist protocol)
Not yet recruiting
- Diminished Ovarian Reserve
- Dydrogesterone priming ovarian stiumulation protocol
- GnRH antagonist protocol
- (no location specified)
Apr 26, 2023
IVF Trial (Progesterone 200 MG, Ganirelix Acetate)
Not yet recruiting
- IVF
- Progesterone 200 MG
- Ganirelix Acetate
- (no location specified)
Jul 12, 2023
Endometriosis, Adenomyosis, Infertility, Female Trial in Suresnes (GnRH agonist)
Recruiting
- Endometriosis
- +2 more
- GnRH agonist
-
Suresnes, FranceHopital Foch
Aug 2, 2022
Kallmann Syndrome, Idiopathic Hypogonadotropic Hypogonadism, GnRH Deficiency Trial in Boston (gonadotropin releasing hormone
Completed
- Kallmann Syndrome
- +2 more
- gonadotropin releasing hormone (GnRH)
-
Boston, MassachusettsMassachusetts General Hospital
Jun 29, 2022
Submucous Leiomyoma of Uterus Trial in Hangzhou (Zoladex, Mifepristone Oral Tablet)
Not yet recruiting
- Submucous Leiomyoma of Uterus
- Zoladex
- Mifepristone Oral Tablet
-
Hangzhou, Zhejiang, ChinaWomen's Hospital School of Medicine Zhejiang University
Jun 7, 2023
Reproductive Disorder Trial in Boston (kisspeptin 112-121, GnRH)
Enrolling by invitation
- Reproductive Disorder
- kisspeptin 112-121
- GnRH
-
Boston, MassachusettsMassachusetts General Hospital
Jun 12, 2023
Prostate Cancer, Prostatic Tumors Trial in Boston, Foxboro (Relugolix, Leuprolide)
Not yet recruiting
- Prostate Cancer
- Prostatic Neoplasms
-
Boston, Massachusetts
- +2 more
Mar 1, 2023
Ovarian Response in Oocyte Donors Triggered With GnRH Agonists
Completed
- Poor Response to Ovulation Induction
-
Barcelona, SpainClinica EUGIN
Jul 20, 2022
Polycystic Ovary Syndrome, Hypertension Trial in New Haven (GnRH antagonist, GnRH antagonist + MethylTESTOSTERone 5 MG)
Completed
- Polycystic Ovary Syndrome
- Hypertension
- GnRH antagonist
- GnRH antagonist + MethylTESTOSTERone 5 MG
-
New Haven, ConnecticutThe John B Pierce Laboratory
Dec 8, 2022
Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A
Not yet recruiting
- Metastatic Prostate Cancer
- +2 more
- Darolutamide
- +4 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 14, 2022
IVF, GnRH Antagonist, PPOS Trial in Shanghai (Progesterone, GnRH Antagonist)
Recruiting
- IVF
- +2 more
- Progesterone
- GnRH Antagonist
-
Shanghai, ChinaShangHai JIAI Genetics&IVF Institute
Mar 28, 2022
Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Euploid Rate Trial in Shanghai (GnRH antagonist, oral
Recruiting
- Preimplantation Genetic Testing
- +3 more
- GnRH antagonist
- oral Duphaston
-
Shanghai, Shanghai, ChinaShanghai JiAi Genetics & IVF Institute
Mar 28, 2022
Down Syndrome, Cognitive Decline, Alzheimer, Early Onset Trial in Geneva, Lausanne (GnRH, gonadorelin acetate, 0.9% NaCl)
Recruiting
- Down Syndrome
- +3 more
- GnRH, gonadorelin acetate
- 0.9% NaCl
-
Geneva, GE, Switzerland
- +1 more
Feb 23, 2022
Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Polycystic Ovarian Syndrome Trial (GnRH antagonist, MPA)
Not yet recruiting
- Preimplantation Genetic Testing
- +3 more
- GnRH antagonist
- MPA
- (no location specified)
Apr 9, 2022